We are live on
!
Find out more
Cogent Biosciences
COGT
COGT
25 hedge funds and large institutions have $3.75M invested in Cogent Biosciences in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.49% less ownership
Funds ownership: 7.92% → 7.43% (-0.49%)
7% less funds holding
Funds holding: 27 → 25 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
46% less capital invested
Capital invested by funds: $6.99M → $3.75M (-$3.24M)
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
1
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$13.4K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$6.84K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.89K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$3.52K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$61 |
Top Sellers
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$106K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$97K |
| 3 |
Renaissance Technologies
New York
|
-$63.1K |
| 4 |
Morgan Stanley
New York
|
-$62K |
| 5 |
Millennium Management
New York
|
-$34.4K |
